Search research articles
Contact Us
Filters
Showing results (51-60 of 83) with videos related to
Page
of 9
Sort By:
Terapevticheskii Arkhiv
|
December 21, 2020
[Results of decision support system implementation for prescribing anticoagulants to patients with atrial fibrillation in hospital]
A A Chernov, E B Kleymenova, D A Sychev, et al.
Advances in Gerontology = Uspekhi Gerontologii
|
June 26, 2025
[Features of clinical and laboratory parameters in elderly patients with acute coronary syndrome.]
A S Markova, O T Bogova, K B Mirzaev, et al.
Kardiologiia
|
February 4, 2019
O A Baturina, D A Andreev, N A Ananicheva, et al.
Molecular Biology Reports
|
May 19, 2019
Genotyping and phenotyping CYP3A4\CYP3A5: no association with antiplatelet effect of clopidogrel
K B Mirzaev, K I Samsonova, P P Potapov, et al.
Terapevticheskii Arkhiv
|
October 15, 2024
[Detection of anticoagulant medication errors by triggers]
V A Otdelenov, E B Kleymenova, M D Nigmatkulova, et al.
Klinicheskaia Meditsina
|
January 31, 2009
[Importance of genetic polymorphism of cytochrome P450 isoenzymes for the choice and regimes of antidepressant and antipsychotic dosing on an individual basis]
M I Savel'eva, D A Sychev, R E Kazakov, et al.
Canadian Journal of Physiology and Pharmacology
|
May 18, 2019
Effects of CYP2D6 activity on the efficacy and safety of mirtazapine in patients with depressive disorders and comorbid alcohol use disorder
M S Zastrozhin, V Y Skryabin, V V Smirnov, et al.
Kardiologiia
|
April 24, 2008
[Cytochrome P4502C9(CYP2C9) gene polymorphism and safety of therapy with warfarin]
Iu A Mikheeva, E S Kropacheva, I V Ignat'ev, et al.
Terapevticheskii Arkhiv
|
October 26, 2022
[CYP2D6 gene polymorphic markers role in determining the optimal treatment tactics for portal hypertension in patients with liver cirrhosis]
D A Sychev, A I Parusov, I D Loranskaya, et al.
Kardiologiia
|
September 10, 2025
The Effectiveness and Profitability of Different Antithrombotic Therapy Regimens in Patients with Type 2 Diabetes Mellitus During 1 Year of Follow-Up after an Exacerbation of Coronary Heart Disease According to the Study ORACLE II
Yu M Chichkov, L O Minushkina, V A Brazhnik, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 83) with videos related to
Sort By:
Page
of 9
Terapevticheskii Arkhiv
|
December 21, 2020
[Results of decision support system implementation for prescribing anticoagulants to patients with atrial fibrillation in hospital]
A A Chernov, E B Kleymenova, D A Sychev, et al.
Advances in Gerontology = Uspekhi Gerontologii
|
June 26, 2025
[Features of clinical and laboratory parameters in elderly patients with acute coronary syndrome.]
A S Markova, O T Bogova, K B Mirzaev, et al.
Kardiologiia
|
February 4, 2019
O A Baturina, D A Andreev, N A Ananicheva, et al.
Molecular Biology Reports
|
May 19, 2019
Genotyping and phenotyping CYP3A4\CYP3A5: no association with antiplatelet effect of clopidogrel
K B Mirzaev, K I Samsonova, P P Potapov, et al.
Terapevticheskii Arkhiv
|
October 15, 2024
[Detection of anticoagulant medication errors by triggers]
V A Otdelenov, E B Kleymenova, M D Nigmatkulova, et al.
Klinicheskaia Meditsina
|
January 31, 2009
[Importance of genetic polymorphism of cytochrome P450 isoenzymes for the choice and regimes of antidepressant and antipsychotic dosing on an individual basis]
M I Savel'eva, D A Sychev, R E Kazakov, et al.
Canadian Journal of Physiology and Pharmacology
|
May 18, 2019
Effects of CYP2D6 activity on the efficacy and safety of mirtazapine in patients with depressive disorders and comorbid alcohol use disorder
M S Zastrozhin, V Y Skryabin, V V Smirnov, et al.
Kardiologiia
|
April 24, 2008
[Cytochrome P4502C9(CYP2C9) gene polymorphism and safety of therapy with warfarin]
Iu A Mikheeva, E S Kropacheva, I V Ignat'ev, et al.
Terapevticheskii Arkhiv
|
October 26, 2022
[CYP2D6 gene polymorphic markers role in determining the optimal treatment tactics for portal hypertension in patients with liver cirrhosis]
D A Sychev, A I Parusov, I D Loranskaya, et al.
Kardiologiia
|
September 10, 2025
The Effectiveness and Profitability of Different Antithrombotic Therapy Regimens in Patients with Type 2 Diabetes Mellitus During 1 Year of Follow-Up after an Exacerbation of Coronary Heart Disease According to the Study ORACLE II
Yu M Chichkov, L O Minushkina, V A Brazhnik, et al.
Page
of 9